Indefinite Delivery Contract SPE2DX15D9252

The federal contract IDV SPE2DX15D9252 is a single-award Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,999,999 IDC, valid through December 31, 2025, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide.

The contract covers an extensive portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. Through this IDC and associated delivery orders, DMS Pharmaceutical Group demonstrates its capability to provide a diverse array of pharmaceutical items, including specialized medications like Xolair, Trikafta, Keytruda, Botox, and Nucala, to the Department of Defense. The firm fixed-price delivery orders are not associated with any set-aside designations, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple medical domains.